Robert Baffi, SVP, Technical Operatons at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 1,100 shares at $38.77 ($43K) on 2008-05-30, disclosed to the SEC on 2008-06-03.
Scheduled sale ($43k) by SVP, Technical Operatons under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.62 | 100 | $4K | 9.1% |
| 2 | $38.64 | 100 | $4K | 9.1% |
| 3 | $38.68 | 200 | $8K | 18.2% |
| 4 | $38.70 | 200 | $8K | 18.2% |
| 5 | $38.76 | 100 | $4K | 9.1% |
| 6 | $38.77 | 400 |
| $16K |
| 36.4% |
| Total | $38.71 avg | 1,100 | $43K | 100% |
| Filing → |
| BMRN | SELL | 2017-10-02 | $2.0M | — | Filing → |
| BMRN | SELL | 2016-05-19 | $435K | — | Filing → |
| BMRN | SELL | 2015-03-05 | $1.6M | — | Filing → |